AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Amesite reports a 69% QoQ revenue increase in Q2 2026, expanding its customer base and offerings to post-acute health businesses across the US. The company plans to launch its first AI-powered electronic medical record (EMR) platform by 2026. Amesite's proprietary AI technology has enabled rapid deployment of its NurseMagicTM product family, with excellent customer reviews and increased adoption in post-acute healthcare segments.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet